Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
about
Hemopressin and other bioactive peptides from cytosolic proteins: are these non-classical neuropeptides?Dual effect of Thymosin α 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonists.Proteomic analysis of Pichindé virus infection identifies differential expression of prothymosin-alpha.Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trialThe efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer.Complexes of an alpha thymosin derivative with ¹⁸⁵/¹⁸⁷Re and (⁹⁹m)Tc: structural analysis and initial biological evaluation.Year in review 2013: Critical Care--sepsis.Intrinsic MyD88-Akt1-mTOR Signaling Coordinates Disparate Tc17 and Tc1 Responses during Vaccine Immunity against Fungal Pneumonia.Plasmacytoid dendritic cells prevent cigarette smoke and Chlamydophila pneumoniae-induced Th2 inflammatory responses.Jack of all trades: thymosin α1 and its pleiotropy.Thymosin α1 as a stimulatory agent of innate cell-mediated immune response.A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol.Historical review of thymosin α 1 in infectious diseases.Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients.Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases.Thymosin α1 modifies podosome architecture and promptly stimulates the expression of podosomal markers in mature macrophages.Evaluation of thymosin α 1 in nonclinical models of the immune-suppressing indications melanoma and sepsis.Efficacy of thymosin α1 and interferon α for the treatment of severe acute pancreatitis in a rat model.Production of thymosin alpha1 via non-enzymatic acetylation of the recombinant precursor.Label-free quantification for discovering novel biomarkers in the diagnosis and assessment of disease activity in inflammatory bowel disease.Longitudinal system-based analysis of transcriptional responses to type I interferons.Production of Nα-acetyl Tα1-HSA through in vitro acetylation by RimJ.Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients.Generation and identification of thymic epithelial progenitor cells pTEC by in-vitro processing of human thymic fragments for allotransplantation.Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure.Thymosin α1: burying secrets in the thymus.Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life
P2860
Q27693906-E903982E-EC14-438F-879D-E6B556692EF8Q30375943-08F42AB9-64BA-4409-86B7-796759049A37Q33656417-5A63A190-E783-4A15-8544-2D96A085120FQ33671514-8DE7AAF2-0ED0-4C40-89C1-2799952E6FFEQ33750231-28124ECF-E06D-46FA-AC15-E90FC9D3C4C9Q33900846-A8F2ABF7-7F3D-4054-B2D0-FB831F69FB8DQ34300980-B5235C4C-C8C4-4F2D-B19D-43137528EA59Q35091080-0DC70AD9-E939-4D5A-901D-C3FB4E61985BQ35772809-4F76CE62-1199-4C92-8E2F-2D6A16B02F67Q37854057-D77815A5-B819-44E7-8528-5EB2E5778BF6Q38050450-C89E1AC6-B850-42C1-A4D8-C5C09155B48CQ38050836-81AEFA79-86E1-46C4-BF50-D1A07208871FQ38409514-C3A6FB47-58BF-42F0-80F7-2EF9A95C429CQ38534271-E08EAF05-F0EB-495B-94EF-481D51DD3F7CQ38920482-675185B6-4D45-45A2-AECA-06D38A5FA8CCQ39650675-B712D6BD-B722-4940-876E-14C9FA984D6DQ40812029-61FF76B3-B86E-4154-8973-7FE693179D7FQ41509426-D538E71F-368F-4A49-BD4A-E5E38192029DQ42604070-F9AFE8C0-DEDB-4A93-A49C-48C4481845D4Q43090553-CC7F5B60-4B86-4BAC-B479-FB5444AAA895Q43497860-8A849AD1-59D6-47D2-B6BD-A35113CBC1CFQ46262683-CD8D90E6-A2C4-454D-B982-90D99109C181Q47120475-03161AB0-9D50-4B7E-BD93-C6B3160C1DACQ47993433-986C16F0-198F-4940-B414-E1A2AE9E78F8Q51886914-81B32D63-796E-4839-A51B-E6B2FE6B9725Q52653082-3D829525-3C0E-43A1-B5DB-B162A782DA1EQ52935650-48D041F5-C3C0-430A-8B53-D17BB4323AB5Q58771453-D90D5FB2-D194-4321-970E-321B207B39F1
P2860
Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
@en
type
label
Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
@en
prefLabel
Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
@en
P2093
P2860
P50
P356
P1476
Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
@en
P2093
Claudia Montagnoli
Enrico Garaci
Francesco Bistoni
Guido Rasi
Pierluigi Bonifazi
Roberta Gaziano
Silvia Bozza
P2860
P304
P356
10.1196/ANNALS.1415.002
P407
P577
2007-05-10T00:00:00Z